What is the role of barbiturates (such as phenobarbital) in the treatment of epilepsy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Role of Barbiturates in Epilepsy Treatment

Barbiturates, particularly phenobarbital, have limited utility in modern epilepsy treatment due to their significant cognitive and behavioral side effects, though they remain effective for certain seizure types and in status epilepticus when other medications fail. 1, 2

Efficacy in Seizure Control

Phenobarbital has demonstrated effectiveness in:

  • Generalized tonic-clonic seizures 1
  • Cortical focal seizures 3
  • Status epilepticus (58.2% efficacy in terminating seizures in refractory cases) 1

The therapeutic anticonvulsant level of phenobarbital in serum is 10-25 μg/mL 3. Phenobarbital exerts its anticonvulsant effects through:

  • Increasing GABA-ergic inhibition
  • Decreasing glutamatergic excitation by inhibiting AMPA receptors 4
  • Limiting seizure spread and raising seizure threshold 3

Current Position in Treatment Algorithm

Status Epilepticus

  1. First-line: Benzodiazepines
  2. Second-line: Levetiracetam, valproate, or phenytoin
  3. Third-line: Phenobarbital may be considered when other options fail 1, 2

Chronic Epilepsy Management

Phenobarbital is generally not considered a first-choice drug for chronic epilepsy management in developed countries due to:

  • Cognitive and behavioral side effects 5, 6
  • Risk of developing refractoriness (particularly in partial seizures) after approximately 6 years of use 7
  • Availability of better-tolerated newer antiepileptic medications 6

Adverse Effects Profile

Major Concerns

  • Cognitive effects: Memory impairment and decreased cognitive function, particularly at higher doses 5, 6
  • Behavioral problems: Exacerbation of hyperactivity, sleep disorders, and depression in predisposed individuals 5
  • Respiratory depression: Dose-dependent effect on the medullary respiratory center 3
  • Hypotension: More common with barbiturates (77%) compared to other agents like propofol (42%) 1

Special Populations

  • Elderly/Debilitated patients: Require reduced dosing due to increased sensitivity 3
  • Patients with intellectual disability: Higher risk of intolerable behavioral side effects 5
  • Patients with renal/hepatic impairment: Require dose adjustments 3
  • Pregnant women: Require careful risk-benefit assessment 6

Administration and Dosing

For status epilepticus:

  • Loading dose: 10-20 mg/kg IV 2
  • Time to peak brain concentration: 15+ minutes (important consideration in status epilepticus) 3
  • Risk of overshooting therapeutic levels if administered continuously until seizures stop 3

For chronic epilepsy management:

  • Once-daily dosing may be effective for some patients with generalized epilepsy 8
  • Lower doses may minimize cognitive side effects 5

Specific Clinical Scenarios Where Phenobarbital May Still Be Useful

  1. Emergency control of status epilepticus when other medications have failed 1, 4
  2. Resource-limited settings due to low cost 4, 6
  3. Select cases of generalized epilepsy with normal intelligence where low-dose phenobarbital has proven effective 8

Practical Considerations for Use

  • Monitor for respiratory depression and hypotension, particularly with IV administration 1, 3
  • When administering IV, use larger veins to minimize irritation and thrombosis risk 3
  • Avoid intraarterial injection which can lead to severe consequences including gangrene 3
  • For long-term use, gradual discontinuation is recommended to prevent withdrawal symptoms 3
  • Regular monitoring of drug levels is advised for optimal therapeutic effect 2

Despite its limitations, phenobarbital remains in the treatment arsenal for specific epilepsy scenarios, particularly in emergency situations and resource-limited settings, though newer antiepileptic drugs with better side effect profiles are generally preferred for long-term management.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of New-Onset Seizures in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Barbiturates in the treatment of epilepsy in people with intellectual disability.

Journal of intellectual disability research : JIDR, 1998

Research

Side effects of phenobarbital in epilepsy: a systematic review.

Epileptic disorders : international epilepsy journal with videotape, 2011

Research

Phenobarbital still has a role in epilepsy treatment.

Journal of child neurology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.